Shanghai Bio-heart Biological Technology Co., Ltd. (HKG:2185)
5.62
+0.22 (4.07%)
Feb 13, 2026, 4:08 PM HKT
HKG:2185 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 187.38 | 202.39 | 369.44 | 451.32 | 708.53 | 453.67 |
Cash & Short-Term Investments | 312.87 | 202.39 | 369.44 | 451.32 | 708.53 | 453.67 |
Cash Growth | 14.65% | -45.22% | -18.14% | -36.30% | 56.18% | 2094.60% |
Other Receivables | 2.49 | - | 6.12 | 5.8 | 8.91 | 2.31 |
Receivables | 14.66 | - | 6.12 | 5.8 | 8.91 | 2.31 |
Inventory | 23.13 | 18.33 | 3.98 | - | - | - |
Other Current Assets | - | 78.31 | 28.93 | 84.41 | 39.08 | 14.78 |
Total Current Assets | 422.61 | 299.03 | 408.47 | 541.53 | 756.53 | 470.77 |
Property, Plant & Equipment | 48.64 | 51.58 | 30.91 | 75.98 | 72.26 | 20.27 |
Long-Term Investments | 86.45 | 53.91 | 87.06 | 73.23 | - | - |
Goodwill | 144.63 | 144.63 | 144.63 | 144.63 | 144.63 | 144.63 |
Other Intangible Assets | 132.95 | 137.59 | 137.71 | 137.54 | 137.2 | 137.2 |
Long-Term Deferred Charges | - | - | - | - | - | 8.27 |
Other Long-Term Assets | 43.14 | 47.05 | 9.12 | 8.61 | 4.3 | 3.9 |
Total Assets | 878.42 | 733.78 | 817.9 | 981.52 | 1,115 | 785.04 |
Accounts Payable | 0 | 0.1 | - | - | 0.01 | 0.01 |
Accrued Expenses | 6.61 | 13.77 | 8.6 | 8.02 | 9.14 | 4.7 |
Current Portion of Leases | 1.27 | 1.27 | 1.58 | 7.62 | 7.31 | 1.24 |
Current Unearned Revenue | 18.46 | - | 3.39 | 0.96 | 0.98 | 0.52 |
Other Current Liabilities | 7.09 | 4.52 | 6.5 | 12.25 | 19.37 | 7.4 |
Total Current Liabilities | 33.42 | 19.65 | 20.07 | 28.85 | 36.81 | 13.87 |
Long-Term Leases | 6.4 | 7.01 | 0.18 | 10.49 | 15.14 | 0.08 |
Long-Term Unearned Revenue | 6 | 6 | 3.21 | 6.55 | 7.52 | 6.6 |
Long-Term Deferred Tax Liabilities | 19.89 | 20.58 | 20.58 | 20.58 | 20.58 | 20.58 |
Total Liabilities | 224.62 | 53.24 | 44.04 | 66.47 | 80.04 | 41.13 |
Common Stock | 243.94 | 243.94 | 243.94 | 243.94 | 243.94 | 220 |
Additional Paid-In Capital | 662.42 | 662.42 | 662.42 | 662.42 | 662.42 | 304.29 |
Retained Earnings | -964.49 | - | - | -673.44 | -469.21 | -107.76 |
Treasury Stock | -29.44 | -29.44 | -29.44 | -29.44 | - | - |
Comprehensive Income & Other | 565.23 | -216.45 | -128.51 | 679.74 | 558.54 | 283.55 |
Total Common Equity | 477.66 | 660.47 | 748.41 | 883.21 | 995.69 | 700.09 |
Minority Interest | 176.14 | 20.07 | 25.45 | 31.84 | 39.19 | 43.82 |
Shareholders' Equity | 653.8 | 680.53 | 773.86 | 915.05 | 1,035 | 743.91 |
Total Liabilities & Equity | 878.42 | 733.78 | 817.9 | 981.52 | 1,115 | 785.04 |
Total Debt | 7.67 | 8.28 | 1.76 | 18.11 | 22.45 | 1.32 |
Net Cash (Debt) | 305.2 | 194.1 | 367.68 | 433.21 | 686.09 | 452.35 |
Net Cash Growth | 12.25% | -47.21% | -15.13% | -36.86% | 51.67% | 2237.85% |
Net Cash Per Share | 1.25 | 0.80 | 1.51 | 1.78 | 3.11 | 3.31 |
Filing Date Shares Outstanding | 243.42 | 243.42 | 243.42 | 243.42 | 243.94 | 220 |
Total Common Shares Outstanding | 243.42 | 243.42 | 243.42 | 243.42 | 243.94 | 220 |
Working Capital | 389.19 | 279.38 | 388.4 | 512.68 | 719.72 | 456.9 |
Book Value Per Share | 1.96 | 2.71 | 3.07 | 3.63 | 4.08 | 3.18 |
Tangible Book Value | 200.07 | 378.25 | 466.07 | 601.04 | 713.86 | 418.26 |
Tangible Book Value Per Share | 0.82 | 1.55 | 1.91 | 2.47 | 2.93 | 1.90 |
Buildings | - | 20.25 | - | - | - | - |
Machinery | - | 39.31 | 53.24 | 38.66 | 33.57 | 29.62 |
Construction In Progress | - | - | - | 8.16 | 19.63 | - |
Leasehold Improvements | - | 22.38 | 21.82 | 61.85 | 31.52 | 14.61 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.